Header Logo

Neilayan Sen

Concepts (71)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology
3
2019
14
0.450
Why?
Pancreatic Neoplasms
1
2014
94
0.410
Why?
Employment
2
2018
38
0.280
Why?
Chemoradiotherapy
2
2019
61
0.260
Why?
Sarcoma
2
2019
147
0.230
Why?
Internship and Residency
2
2019
214
0.230
Why?
Carcinoma, Non-Small-Cell Lung
2
2017
240
0.210
Why?
Lung Neoplasms
2
2017
551
0.180
Why?
Human papillomavirus 16
1
2019
6
0.160
Why?
Oropharyngeal Neoplasms
1
2019
20
0.160
Why?
Biopsy, Fine-Needle
1
2019
63
0.150
Why?
Career Choice
1
2018
25
0.150
Why?
Tongue Neoplasms
1
2018
19
0.150
Why?
Neoadjuvant Therapy
2
2019
64
0.150
Why?
Carcinoma, Squamous Cell
1
2019
172
0.140
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
245
0.130
Why?
Radiosurgery
1
2017
37
0.130
Why?
Prognosis
2
2019
804
0.120
Why?
Brachytherapy
1
2016
46
0.120
Why?
Radiotherapy, Adjuvant
1
2014
51
0.110
Why?
Humans
10
2019
26976
0.100
Why?
United States
4
2019
2029
0.100
Why?
Retrospective Studies
4
2019
3543
0.080
Why?
Treatment Outcome
4
2019
3526
0.070
Why?
Chi-Square Distribution
2
2018
139
0.070
Why?
Male
6
2019
14756
0.070
Why?
Female
6
2019
15196
0.070
Why?
Disease-Free Survival
2
2018
177
0.070
Why?
Databases, Factual
2
2019
352
0.060
Why?
Neoplasm Staging
2
2018
364
0.060
Why?
Adult
4
2019
7877
0.060
Why?
Cohort Studies
2
2019
1900
0.050
Why?
Aged
3
2019
9068
0.040
Why?
Genetic Heterogeneity
1
2019
9
0.040
Why?
Mesna
1
2019
3
0.040
Why?
Population Density
1
2018
7
0.040
Why?
Job Application
1
2018
6
0.040
Why?
Ifosfamide
1
2019
13
0.040
Why?
Cities
1
2018
16
0.040
Why?
Clinical Decision-Making
1
2019
46
0.040
Why?
Organ Sparing Treatments
1
2019
12
0.040
Why?
Reference Values
1
2019
184
0.040
Why?
Schools, Medical
1
2018
27
0.040
Why?
Consumer Behavior
1
2018
23
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p16
1
2018
29
0.040
Why?
Leg
1
2019
50
0.040
Why?
Doxorubicin
1
2019
57
0.040
Why?
Arm
1
2019
83
0.040
Why?
Neoplasm Invasiveness
1
2018
93
0.040
Why?
Analysis of Variance
1
2018
254
0.040
Why?
Combined Modality Therapy
1
2019
305
0.040
Why?
Survival Rate
1
2018
344
0.030
Why?
Professional Practice Location
1
2017
2
0.030
Why?
Academies and Institutes
1
2017
11
0.030
Why?
Censuses
1
2017
9
0.030
Why?
Radiotherapy Dosage
1
2017
100
0.030
Why?
Patient Safety
1
2017
36
0.030
Why?
Kaplan-Meier Estimate
1
2017
176
0.030
Why?
Risk Assessment
1
2019
626
0.030
Why?
Societies, Medical
1
2017
123
0.030
Why?
Registries
1
2017
199
0.030
Why?
Age Factors
1
2018
773
0.030
Why?
Middle Aged
2
2019
9017
0.030
Why?
Chemoradiotherapy, Adjuvant
1
2015
16
0.030
Why?
Survival Analysis
1
2015
261
0.030
Why?
Surveys and Questionnaires
1
2018
1135
0.030
Why?
Adolescent
1
2018
2147
0.020
Why?
Young Adult
1
2018
2016
0.020
Why?
Prospective Studies
1
2017
1782
0.020
Why?
Follow-Up Studies
1
2017
1798
0.020
Why?
Aged, 80 and over
1
2017
4833
0.020
Why?
Sen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (19)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_